Parrera, G. S., Astacio, H., Tunga, P., Anderson, D. M., Hall, C. L., & Richardson, J. S. (2021). Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review. MDPI AG.
Chicago Style (17th ed.) CitationParrera, Geraldine S., Hugo Astacio, Priya Tunga, Deborah M. Anderson, Christine L. Hall, and Jason S. Richardson. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review. MDPI AG, 2021.
MLA citiranjeParrera, Geraldine S., et al. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review. MDPI AG, 2021.